See inside every stock. Pro
S&P 5007,723▲ 0.60%Nasdaq26,478▲ 1.18%Dow Jones52,378▲ 0.03%Nasdaq 10029,651▲ 1.29%VIX17.52▼ 4.73%US Dollar102.35▲ 0.39%Gold spot4,006▲ 0.30%WTI101.94▲ 2.04%
← YUBICO page
XStocksXray
Market X-Ray report · 27 October 2026

Yubico AB (YUBICO)

Nasdaq Stockholm · Sweden · prices in SEK · close of 27 Oct 2026

Key indicators

Last closeSEK 156.00
52-week range29.55 – 156.00
Return, 1 month / 3 months+46.5% / +151.4%
Return, 1 year / 3 years+74.9% / +60.3%
TrendUptrend
RSI (14)85
Volatility (1 year)80.0%
Worst drawdown (1 year)-68.1%
Average daily value traded45.45M SEK
Dividend yield–

Market X-Ray price-based

74/ 100 · High confidence · ahead of 86% of stocks on this exchange
Trend99
Momentum93
Stability (higher is calmer)21
Liquidity91
Income–

Five-year price chart navy: price · brown: 200-day average

13.4694.301752563372021-102023-012024-042025-072026-10

About the company

Yubico makes hardware authentication devices, most notably the YubiKey, a small key that plugs into a computer or connects wirelessly to confirm a user's identity when signing in to online services. The company serves businesses, government bodies and individual customers who want stronger protection than passwords alone. Yubico is based in Sweden and also has a substantial presence in the United States, and it takes part in developing open authentication standards.

The shares are listed on the Nasdaq Stockholm in Sweden under the code YUBICO, and the price on this page is in Swedish kronor (SEK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Yubico AB (YUBICO) trades on the Nasdaq Stockholm in Sweden. It last closed at SEK 156.00 on 27 October 2026.

Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 130 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 74.9% and over the last three months it rose 151.4%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Yubico AB (YUBICO)

The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Stockholm

Lens and metricValueScoreReading
Trend99 · StrongTrading above its long-term averages and near its highs.
Above 200-day average126.2%
From 52-week high0.0%
Momentum93 · StrongRising faster than most stocks on this exchange.
3-month return151.4%
6-month return288.1%
12-month return, skipping the last month19.4%
Stability (higher is calmer)21 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)80.0%
Worst drawdown, 1 year (smaller is calmer)-68.1%
Liquidity91 · StrongTrades actively.
Average daily value traded45.45M SEK
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Momentum: Rising faster than most stocks on this exchange.
  • Liquidity: Trades actively.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week+34.3%
1 month+46.5%
3 months+151.4%
6 months+288.1%
1 year+74.9%
3 years+60.3%
5 years+53.3%

Signals

50-day / 200-day average104.85 / 68.97
Golden / death cross (60 days)Golden, 52 days ago
New 52-week highYes
Bullish RSI divergenceNo
Average daily range (ATR)6.57

Technical summary

DailyBullish12 bullish · 0 neutral · 4 bearish
WeeklyStrongly bullish11 bullish · 0 neutral · 1 bearish
MonthlyStrongly bullish6 bullish · 1 neutral · 1 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Stockholm; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 28 Oct 2026